Researchers at the University of Massachusetts Amherst have invented a new, sprayable delivery system for psoriasis ...

According to a study published in Biomaterials Advances, scientists at the University of Copenhagen have developed a patch ...

Living in places with more air pollution raises the risk of eczema, a chronic condition that causes dry, itchy and inflamed ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

A dermatophyte known as Trichophyton mentagrophytes genotype VII (TMVII) has been identified as the cause of an emerging ...

I used to have thick, black long hair which was 24 inches." Emmy said her scalp was engulfed in psoriasis and she told her ...

Successful go-public transaction and over $475 million raised this year provides cash runway through multiple clinical ...

Continued to advance three clinical programs in immune-mediated diseases: The Phase 3 ONWARD program for ESK-001 in moderate-to-severe plaque psoriasis consists of two parallel 24-week global Phase 3 ...

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritisTwo trials for ...

The New Jersey-based drugmaker is trying to get the courts’ backing to pay hospitals after-the-fact rebates for two drugs in ...

Against the background described above, "betting big" on a topical treatment for plaque psoriasis make a lot of sense, ...

Barbara Paldus is the founder of biotech company Codex Labs and an expert on all things skincare, skin health and skin ...